Insights

BioMed X Partnership Daiichi Sankyo has partnered with BioMed X, a biomedical research institute, to collaborate on the development of potential cancer drugs. This collaboration presents a sales opportunity to offer innovative cancer treatment solutions.

Investment in Manufacturing Facility Daiichi Sankyo announced a $150 million investment in a new manufacturing facility in Shanghai for antibody-drug conjugates (ADCs). This investment signifies growth potential and opens avenues for selling ADCs to a wider market.

RNA Medicines Development Daiichi Sankyo is developing cell-targeted RNA medicines and has announced a research collaboration with Nosis Biosciences. This cutting-edge approach presents a sales opportunity to offer advanced RNA therapies for various diseases.

CEO Promotion and Leadership Change Hiroyuki Okuzawa was promoted to CEO of Daiichi Sankyo, taking over from Sunao Manabe. This leadership change could lead to new strategic initiatives and partnerships, creating sales opportunities for new healthcare solutions.

COVID-19 Vaccine Launch Daiichi Sankyo launched an LNP-mRNA COVID-19 vaccine during the pandemic. With the ongoing focus on vaccination efforts globally, there is a sales opportunity to provide innovative vaccine solutions to combat infectious diseases.

Similar companies to Daiichi Sankyo

Daiichi Sankyo Tech Stack

Daiichi Sankyo uses 8 technology products and services including Cloudflare, Open Graph, Slick, and more. Explore Daiichi Sankyo's tech stack below.

Cloudflare
Content Management System
Open Graph
Content Management System
Slick
Javascript Libraries
Azure Front Door
Load Balancers
Microsoft Azure
Platform As A Service
X-XSS-Protection
Security
Cloudflare Bot Management
Security
DX Delivery Service
Transportation And Fleet Management

Media & News

Daiichi Sankyo's Email Address Formats

Daiichi Sankyo uses at least 3 format(s):

Daiichi Sankyo Email Formats	Example	Percentage
FLast@dsi.com	JDoe@dsi.com	89%
LFirst@dsi.com	DJohn@dsi.com	6%
FiLast@dsi.com	JoDoe@dsi.com	2%
First.Last@dsi.com	John.Doe@dsi.com	1%
FL@dsi.com	JD@dsi.com	1%
FirLast@dsi.com	JohDoe@dsi.com	1%
FLast@daiichisankyo-us.com	JDoe@daiichisankyo-us.com	94%
Last@daiichisankyo-us.com	Doe@daiichisankyo-us.com	6%
First.Last@daiichisankyo.com	John.Doe@daiichisankyo.com	92%
FLast@daiichisankyo.com	JDoe@daiichisankyo.com	7%
FirstLast@daiichisankyo.com	JohnDoe@daiichisankyo.com	1%

Frequently Asked Questions

Where is Daiichi Sankyo's headquarters located?

Daiichi Sankyo's main headquarters is located at 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo Tokyo, 103-8426 JP. The company has employees across 6 continents, including North AmericaAsiaEurope.

What is Daiichi Sankyo's phone number?

You can contact Daiichi Sankyo's main corporate office by phone at

+1-405-373-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Daiichi Sankyo's official website and social media links?

Daiichi Sankyo's official website is daiichisankyo.com and has social profiles on LinkedIn.

How much revenue does Daiichi Sankyo generate?

As of April 2025, Daiichi Sankyo's annual revenue reached $11B.

What is Daiichi Sankyo's SIC code NAICS code?

Daiichi Sankyo's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Daiichi Sankyo have currently?

As of April 2025, Daiichi Sankyo has approximately 10K employees across 6 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: A. S.Chief Executive Officer: F. S.Chief Executive Officer: G. D.. Explore Daiichi Sankyo's employee directory with LeadIQ.

What industry does Daiichi Sankyo belong to?

Daiichi Sankyo operates in the Pharmaceutical Manufacturing industry.

What technology does Daiichi Sankyo use?

Daiichi Sankyo's tech stack includes CloudflareOpen GraphSlickAzure Front DoorMicrosoft AzureX-XSS-ProtectionCloudflare Bot ManagementDX Delivery Service.

What is Daiichi Sankyo's email format?

Daiichi Sankyo's email format typically follows the pattern of . Find more Daiichi Sankyo email formats with LeadIQ.

When was Daiichi Sankyo founded?

Daiichi Sankyo was founded in 2007.

Daiichi Sankyo

Pharmaceutical ManufacturingTokyo, Japan10001+ Employees

Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need. 

For all other inquiries about Daiichi Sankyo such as products or careers, please visit our website www.daiichisankyo.com.